✦ LIBER ✦

Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies

✍ Scribed by Jiang, X; Zhao, Y; Smith, C; Gasparetto, M; Turhan, A; Eaves, A; Eaves, C

Book ID: 110057126
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 311 KB
Volume: 21
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2404609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Contribution of BCR–ABL-independent acti

Contribution of BCR–ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells

✍ Takeru Nambu; Norie Araki; Aiko Nakagawa; Akihiko Kuniyasu; Tatsuya Kawaguchi; A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 502 KB

1009 Targeting Chronic Myeloid Leukemia

1009 Targeting Chronic Myeloid Leukemia Stem/progenitor Cells by Effective Inhibition of a Novel AHI-1-BCR-ABL-JAK2 Interaction Complex

✍ X. Jiang; M. Chen; P. Gallipoli; D. Lai; A. Ringrose; A. Turhan; C. Eaves; T. Ho 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Stem cell transplantation for patients w

Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315I

✍ Nikolai Velev; Jorge Cortes; Richard Champlin; Dan Jones; Gabriela Rondon; Sergi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

β-Catenin is essential for survival of l

β-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia

✍ Hu, Y; Chen, Y; Douglas, L; Li, S 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 356 KB

O37 BCR-ABL kinase domain mutations and

O37 BCR-ABL kinase domain mutations and clonal evolution as major causes of resistance to targeted therapy in chronic myelogenous leukemia

✍ H. Andrikovics; N. Meggyesi; S. Lueff; A. Batai; E. Adam; A. Kozma; G. Halm; S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Hb-Hana family is the first described example, where partial glutathione reductase deficiency represents a modifying factor of clinical manifestation of unstable hemoglobinopathy. Grant support: MSM 6198959205 and MSM 6198959216. O35 A prognostic impact of transfusion dependency on survival of pati

Imatinib mesylate (STI571) abrogates the

Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair

✍ Ireneusz Majsterek; Tomasz Sliwinski; Tomasz Poplawski; Dariusz Pytel; Michal Ko 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 233 KB